Copyright: ©Author(s) 2026.
World J Gastroenterol. Apr 21, 2026; 32(15): 116083
Published online Apr 21, 2026. doi: 10.3748/wjg.v32.i15.116083
Published online Apr 21, 2026. doi: 10.3748/wjg.v32.i15.116083
Table 1 Baseline demographics and medication use, mean ± SD/n (%)
| Variable | Non-CAP (n = 139) | CAP-assisted (n = 67) | P value |
| Age (years) | 62.97 ± 19.72 | 59.82 ± 22.44 | 0.348 |
| Gender (male) | 102 (76.7) | 43 (70.5) | 0.356 |
| Gender (female) | 31 (23.3) | 18 (29.5) | 0.356 |
| Charlson score | 4.62 ± 3.35 | 4.16 ± 2.86 | 0.334 |
| Smoking (yes) | 38 (28.6) | 17 (27.9) | 0.920 |
| NSAID (yes) | 30 (22.6) | 8 (13.1) | 0.124 |
| Clopidogrel (yes) | 17 (12.8) | 9 (14.8) | 0.708 |
| ASA (yes) | 32 (24.1) | 17 (27.9) | 0.571 |
| OAC (yes) | 18 (13.5) | 11 (18.0) | 0.439 |
- Citation: Küçükdemirci Ö, Ayyildiz T, Bas B, Eruzun H, Efe N, Bektas A. Endoscopic transparent cap assisted hemostasis: A multicenter retrospective cohort study. World J Gastroenterol 2026; 32(15): 116083
- URL: https://www.wjgnet.com/1007-9327/full/v32/i15/116083.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i15.116083